Reports & Presentations
Subsidiary Financials 2021 -22
- Glenmark Pharmaceuticals (Australia) Pty Limited
- Glenmark Holding SA La Chaux-de-Fonds
- Glenmark-Pharmaceuticals Ecuador S.A.
- Glenmark Pharmaceuticals Singapore Pte. Ltd.
- Glenmark Pharmaceuticals Europe Ltd., U.K.
- Glenmark Life Sciences Limited
- Glenmark Pharmaceuticals Malaysia Sdn Bhd
- Glenmark Pharmaceuticals (Nigeria) Ltd
- Glenmark Philippines Inc.
- Glenmark Pharmaceuticals S.R.O.
- Glenmark Pharmaceuticals SK, S.R.O.
- Glenmark Pharmaceuticals Peru SAC
- Ichnos Sciences SA
- Glenmark Pharmaceuticals Inc.
- Glenmark Uruguay S.A.
- Glenmark Pharmaceuticals Venezuela, C.A
- Glenmark Dominicana SRL
- Glenmark Pharmaceuticals FZE
- Glenmark South Africa (pty) Ltd
- Glenmark Pharmaceuticals South Africa (pty) Ltd
- Glenmark Pharmaceuticals (Thailand) Co. Ltd
- Glenmark Pharmaceuticals B.V.
- Glenmark Arzneimittel Gmbh
- Glenmark Pharmaceuticals Kenya Ltd
- Viso Farmaceutica S.L., Spain
- Glenmark Pharmaceuticals Distribution s.r.o.
- Glenmark Pharmaceuticals Nordic AB
- GLENMARK PHARMACEUTICALS SP. Z O.O.
